We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+14.09%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$79.1B
AUM Growth
+$7.99B
(+11%)
Cap. Flow
-$5.86B
Cap. Flow
% of AUM
-7.4%
Top 10 Holdings %
Top 10 Hldgs %
22.63%
Holding
2,061
New
445
Increased
504
Reduced
465
Closed
231
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sysco
SYY
|
+$273M |
| 2 |
Waste Management
WM
|
+$168M |
| 3 |
Lowe's Companies
LOW
|
+$160M |
| 4 |
PNC Financial Services
PNC
|
+$154M |
| 5 |
Unilever
UL
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$548M |
| 2 |
Apple
AAPL
|
+$372M |
| 3 |
CSX Corp
CSX
|
+$369M |
| 4 |
Infosys
INFY
|
+$238M |
| 5 |
Kimberly-Clark
KMB
|
+$235M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.16% |
| 2 | Healthcare | 14.65% |
| 3 | Financials | 13.08% |
| 4 | Industrials | 9.66% |
| 5 | Consumer Discretionary | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
LivaNova
LIVN
$4.2B
| $613K | ﹤0.01% |
9,273
+4,263
| +85% | +$237K |
|
802
PTC Therapeutics
PTCT
$6.12B
| $612K | ﹤0.01% |
+10,034
| New | +$591K |
|
803
TJX Companies
TJX
$178B
| $606K | ﹤0.01% |
8,889
+8,847
| +21,064% | +$538K |
|
|
BBL
804
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $605K | ﹤0.01% |
11,421
+1,927
| +20% | +$88.4K |
|
805
Vanguard Morningstar Mid-Cap ETF
VO
$109B
| $599K | ﹤0.01% |
11,600
| – | – |
|
806
SAP
SAP
$238B
| $598K | ﹤0.01% |
4,595
-1,329,518
| -100% | -$172M |
|
807
TriMas Corp
TRS
$1.44B
| $593K | ﹤0.01% |
18,745
-154,780
| -89% | -$4.24M |
|
808
Wells Fargo
WFC
$264B
| $590K | ﹤0.01% |
19,581
| – | – |
|
809
iShares MSCI India ETF
INDA
$6.63B
| $584K | ﹤0.01% |
14,534
-539
| -4% | -$19.7K |
|
810
Air Products & Chemicals
APD
$67.6B
| $575K | ﹤0.01% |
2,107
-932
| -31% | -$262K |
|
|
AZEK
811
DELISTED
The AZEK Co
AZEK
| $572K | ﹤0.01% |
+14,900
| New | +$538K |
|
812
Chubb
CB
$135B
| $567K | ﹤0.01% |
3,692
-722
| -16% | -$101K |
|
813
iShares S&P India Nifty 50 Index Fund
INDY
$569M
| $566K | ﹤0.01% |
13,354
-495
| -4% | -$19K |
|
814
Seagate
STX
$184B
| $559K | ﹤0.01% |
9,000
| – | – |
|
815
Helix Energy Solutions
HLX
$1.41B
| $557K | ﹤0.01% |
132,854
+47,617
| +56% | +$159K |
|
816
iShares Intermediate Government/Credit Bond ETF
GVI
$3.78B
| – | – |
0
| – | – |
|
817
i3 Verticals
IIIV
$342M
| $540K | ﹤0.01% |
+16,266
| New | +$436K |
|
818
Mattel
MAT
$4.3B
| $534K | ﹤0.01% |
+30,671
| New | +$452K |
|
819
General Motors
GM
$76.8B
| $530K | ﹤0.01% |
12,763
+496
| +4% | +$19.3K |
|
820
Impinj
PI
$5.6B
| $525K | ﹤0.01% |
+12,546
| New | +$437K |
|
|
CALY
821
Callaway Golf Company
CALY
$3.14B
| $518K | ﹤0.01% |
+21,586
| New | +$440K |
|
822
Winnebago Industries
WGO
$909M
| $512K | ﹤0.01% |
8,548
+7,998
| +1,454% | +$436K |
|
823
Western Union
WU
$2.21B
| $512K | ﹤0.01% |
23,365
-399,813
| -94% | -$8.67M |
|
824
TechTarget
TTGT
$278M
| $511K | ﹤0.01% |
8,652
-940
| -10% | -$48.6K |
|
825
Endava
DAVA
$156M
| $508K | ﹤0.01% |
6,632
+4,612
| +228% | +$312K |
|
Similar funds
QCM
Lazard Asset Management's Q4 2020 Portfolio in Review
As of Q4 2020, Lazard Asset Management held 2,061 positions worth $79.1B, up 11% from $71.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Lazard Asset Management withdrew a net $5.86B in Q4 2020, closing 231 positions and reducing 465 holdings. Its most notable exit was Unilever NV New York Registry Shares, an estimated $112M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Sotera Health worth $100M.
- Lazard Asset Management's largest Q4 2020 buy was Sotera Health: 3,651,831 shares worth $100M.
- Lazard Asset Management added most to Sysco in Q4 2020, an estimated $273M increase.
- Lazard Asset Management's biggest Q4 2020 reduction was Pfizer, cutting an estimated $548M.
- Lazard Asset Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $112M.
- Lazard Asset Management's ten largest holdings make up 23% of its $79.1B portfolio in Q4 2020.
- Lazard Asset Management opened 445 new positions and closed 231 in Q4 2020.
- Lazard Asset Management's portfolio value rose 11% quarter-over-quarter to $79.1B.
Based on Lazard Asset Management's 13F filing for Q4 2020, filed 11 Feb 2021.